PP
The startup has developed a drug discovery and delivery platform that utilizes proprietary nanotechnology to create oral enzyme therapies. This technology protects enzymes with a nano-shield and targets them to the mucus of the small intestine, reducing the need for multiple pills in the treatment of digestive diseases.
Updated 3 months ago
Funding
$410K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup has developed a drug discovery and delivery platform that utilizes proprietary nanotechnology to create oral enzyme therapies. This technology protects enzymes with a nano-shield and targets them to the mucus of the small intestine, reducing the need for multiple pills in the treatment of digestive diseases.